{"id":"NCT02059291","sponsor":"Novartis Pharmaceuticals","briefTitle":"Study of Efficacy and Safety of Canakinumab in Patients With Hereditary Periodic Fevers","officialTitle":"A Randomized, Double-blind, Placebo Controlled Study of Canakinumab in Patients With Hereditary Periodic Fevers (TRAPS, HIDS, or crFMF), With Subsequent Randomized Withdrawal/Dosing Frequency Reduction and Open-label Long-term Treatment Epochs","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2014-06-27","primaryCompletion":"2017-07-04","completion":"2017-07-04","firstPosted":"2014-02-11","resultsPosted":"2017-03-17","lastUpdate":"2018-05-17"},"enrollment":203,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Hereditary Periodic Fevers"],"interventions":[{"type":"DRUG","name":"Canakinumab","otherNames":["ACZ885"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"crFMF: 150 mg","type":"EXPERIMENTAL"},{"label":"crCMF: placebo","type":"PLACEBO_COMPARATOR"},{"label":"HIDS/MKD: 150 mg","type":"EXPERIMENTAL"},{"label":"HIDS/MKD: placebo","type":"PLACEBO_COMPARATOR"},{"label":"TRAPS: 150 mg","type":"EXPERIMENTAL"},{"label":"TRAPS: placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This study is to determine whether canakinumab is able to induce and maintain a clinically meaningful reduction of disease activity in participants with Hereditary Periodic Fevers (HPF) compared to placebo.","primaryOutcome":{"measure":"Percentage of Participants With Resolution of Initial Flare and Absence of New Flares up to the End of the Randomized Treatment Epoch (16 Weeks)","timeFrame":"16 weeks","effectByArm":[{"arm":"Epoch 2: crFMF: 150 mg","deltaMin":61.29,"sd":null},{"arm":"Epoch 2: crCMF: Placebo","deltaMin":6.25,"sd":null},{"arm":"Epoch 2: HIDS/MKD: 150 mg","deltaMin":35.14,"sd":null},{"arm":"Epoch 2: HIDS/MKD: Placebo","deltaMin":5.71,"sd":null},{"arm":"Epoch 2: TRAPS: 150 mg","deltaMin":45.45,"sd":null},{"arm":"Epoch 2: TRAPS: Placebo","deltaMin":8.33,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.0001"},{"comp":"OG002 vs OG003","p":"0.0020"},{"comp":"OG004 vs OG005","p":"0.0050"}]},"eligibility":{"minAge":"1 Month","sex":"ALL","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":65,"countries":["United States","Belgium","Canada","France","Germany","Hungary","Ireland","Israel","Italy","Japan","Netherlands","Russia","Spain","Switzerland","Turkey (TÃ¼rkiye)","United Kingdom"]},"refs":{"pmids":["37668289","34554243","29768139"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3,"n":4},"commonTop":["Pyrexia","Headache","Abdominal pain","Upper respiratory tract infection","Diarrhoea"]}}